Skip to main content

Emergent BioSolutions CEO: ‘Confrontational’ coverage of vaccine maker puts a target on ‘people doing good’ | COMMENTARY – Baltimore Sun

By April 19, 2021News
NewImage

NewImage

As the CEO of a 2,000-plus person Maryland-based company involved in the COVID-19 response, I have a high tolerance for the obligations that come with it — like spending endless hours trying to explain complicated manufacturing processes to reporters who just learned we existed. Or battling back the misinformation that is used to find fault with the people who are the spine of our nation’s world-leading response to this pandemic.

Image: Manufacturing associates work on a COVID-19 vaccine in one of four flexible manufacturing suites at Emergent BioSolutions’ Bayview facility. (Jerry Jackson/Baltimore Sun) (Jerry Jackson/Baltimore Sun) 

{iframe}https://www-baltimoresun-com.cdn.ampproject.org/c/s/www.baltimoresun.com/opinion/op-ed/bs-ed-op-0415-emergent-biosolutions-20210414-g5vfa2rypvgcflqn7x7jouou2u-story.html?outputType=amp{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.